Genomic Health Announces Positive Preliminary Results Of Oncotype DX® Study In DCIS Breast Cancer
5/25/2011
Genomic Health, Inc. (Nasdaq: GHDX) announced positive preliminary results from a study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National Cancer Institute...
OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test And Clinical Assessment
5/25/2011
A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative assessment alone...
Research Suggests That Lipofilling May Be Safe During Conservation Treatment For Breast Cancer
5/24/2011
A new study has gone some way to answering the question about whether or not a technique called lipofilling is safe for women who are having their breasts reconstructed after surgery for breast cancer. Lipofilling involves taking some fat from another area of a woman's body, such as her abdomen, and using it to fill in small defects or asymmetry that may occur during breast reconstruction...
Consumer Reports: Target Has Best Sunscreen; Some Bad For You Though
5/24/2011
After Consumer Reports tested the ability of 22 sprays, creams and lotions to protect against ultraviolet A and ultraviolet B radiation Target's Up & Up's Sport Continuous SPF 30 brand not only was the best deal on the market, but also won top honor for the all important effectiveness...
Brisk Walking Could Improve Prostate Cancer Outcomes
5/24/2011
Men with prostate cancer can improve their outcomes if they walk briskly for at least three hours a week following their diagnosis, according to a recent study in Cancer Research, a journal of the American Association for Cancer Research. "It appears that men who walk briskly after their diagnosis may delay or even prevent progression of their disease," said lead researcher Erin Richman, Sc.D...
Acetaminophen Linked To Lower Prostate Cancer Risk
5/24/2011
A new study from American Cancer Society researchers finds use of 30 tablets a month or more of acetaminophen for five or more years was associated with an estimated 38% lower risk of prostate cancer...
Acute Lymphoblastic Leukemia Patients Benefit From Antibody-Guided Drug
5/24/2011
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7...
California Companies Target Heart Disease, Cancer With More Than 240 Medicines In Development
5/24/2011
At a time when cancer and heart disease are the nation's and the world's top killers, biopharmaceutical research companies headquartered in California are developing 243 of the 1,186 medicines in development for those dreaded diseases. The California companies are developing 188 of 887 drugs for more than 20 types of cancer and 55 of 299 medicines for heart disease and stroke...
Many Americans may consider giving blood to be an important act of community service, however, less than 10 percent of those who can give actually donate on an annual basis. To help bridge this gap, Nexcare™ Brand, in partnership with America's Blood Centers and the American Red Cross, are proud to announce the third annual Nexcare™ give program...
Exelixis, Inc. (NASDAQ:EXEL) today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology...